Detailed TOC of Dermal Fillers and Botulinum Toxin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
1 Market Overview1.1 Dermal Fillers and Botulinum Toxin Product Introduction
1.2 Global Dermal Fillers and Botulinum Toxin Market Size Forecast
1.2.1 Global Dermal Fillers and Botulinum Toxin Sales Value (2019-2030)
1.2.2 Global Dermal Fillers and Botulinum Toxin Sales Volume (2019-2030)
1.2.3 Global Dermal Fillers and Botulinum Toxin Sales Price (2019-2030)
1.3 Dermal Fillers and Botulinum Toxin Market Trends & Drivers
1.3.1 Dermal Fillers and Botulinum Toxin Industry Trends
1.3.2 Dermal Fillers and Botulinum Toxin Market Drivers & Opportunity
1.3.3 Dermal Fillers and Botulinum Toxin Market Challenges
1.3.4 Dermal Fillers and Botulinum Toxin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dermal Fillers and Botulinum Toxin Players Revenue Ranking (2023)
2.2 Global Dermal Fillers and Botulinum Toxin Revenue by Company (2019-2024)
2.3 Global Dermal Fillers and Botulinum Toxin Players Sales Volume Ranking (2023)
2.4 Global Dermal Fillers and Botulinum Toxin Sales Volume by Company Players (2019-2024)
2.5 Global Dermal Fillers and Botulinum Toxin Average Price by Company (2019-2024)
2.6 Key Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dermal Fillers and Botulinum Toxin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dermal Fillers and Botulinum Toxin
2.9 Dermal Fillers and Botulinum Toxin Market Competitive Analysis
2.9.1 Dermal Fillers and Botulinum Toxin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dermal Fillers and Botulinum Toxin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dermal Fillers
3.1.2 Botulinum Toxin
3.2 Global Dermal Fillers and Botulinum Toxin Sales Value by Type
3.2.1 Global Dermal Fillers and Botulinum Toxin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dermal Fillers and Botulinum Toxin Sales Value, by Type (2019-2030)
3.2.3 Global Dermal Fillers and Botulinum Toxin Sales Value, by Type (%) (2019-2030)
3.3 Global Dermal Fillers and Botulinum Toxin Sales Volume by Type
3.3.1 Global Dermal Fillers and Botulinum Toxin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dermal Fillers and Botulinum Toxin Sales Volume, by Type (2019-2030)
3.3.3 Global Dermal Fillers and Botulinum Toxin Sales Volume, by Type (%) (2019-2030)
3.4 Global Dermal Fillers and Botulinum Toxin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cosmetic
4.1.2 Medical
4.2 Global Dermal Fillers and Botulinum Toxin Sales Value by Application
4.2.1 Global Dermal Fillers and Botulinum Toxin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dermal Fillers and Botulinum Toxin Sales Value, by Application (2019-2030)
4.2.3 Global Dermal Fillers and Botulinum Toxin Sales Value, by Application (%) (2019-2030)
4.3 Global Dermal Fillers and Botulinum Toxin Sales Volume by Application
4.3.1 Global Dermal Fillers and Botulinum Toxin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dermal Fillers and Botulinum Toxin Sales Volume, by Application (2019-2030)
4.3.3 Global Dermal Fillers and Botulinum Toxin Sales Volume, by Application (%) (2019-2030)
4.4 Global Dermal Fillers and Botulinum Toxin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dermal Fillers and Botulinum Toxin Sales Value by Region
5.1.1 Global Dermal Fillers and Botulinum Toxin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2019-2024)
5.1.3 Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2025-2030)
5.1.4 Global Dermal Fillers and Botulinum Toxin Sales Value by Region (%), (2019-2030)
5.2 Global Dermal Fillers and Botulinum Toxin Sales Volume by Region
5.2.1 Global Dermal Fillers and Botulinum Toxin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2019-2024)
5.2.3 Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2025-2030)
5.2.4 Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (%), (2019-2030)
5.3 Global Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
5.4.2 North America Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
5.5.2 Europe Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
5.6.2 Asia Pacific Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
5.7.2 South America Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
5.8.2 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value
6.2.1 Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.3.2 United States Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.4.2 Europe Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.5.2 China Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.6.2 Japan Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.7.2 South Korea Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.8.2 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dermal Fillers and Botulinum Toxin Sales Value, 2019-2030
6.9.2 India Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dermal Fillers and Botulinum Toxin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Dermal Fillers and Botulinum Toxin Product Offerings
7.1.5 AbbVie Recent Development
7.2 Galderma
7.2.1 Galderma Company Information
7.2.2 Galderma Introduction and Business Overview
7.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Galderma Dermal Fillers and Botulinum Toxin Product Offerings
7.2.5 Galderma Recent Development
7.3 LG Life Sciences
7.3.1 LG Life Sciences Company Information
7.3.2 LG Life Sciences Introduction and Business Overview
7.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 LG Life Sciences Dermal Fillers and Botulinum Toxin Product Offerings
7.3.5 LG Life Sciences Recent Development
7.4 Merz
7.4.1 Merz Company Information
7.4.2 Merz Introduction and Business Overview
7.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merz Dermal Fillers and Botulinum Toxin Product Offerings
7.4.5 Merz Recent Development
7.5 Medytox
7.5.1 Medytox Company Information
7.5.2 Medytox Introduction and Business Overview
7.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Medytox Dermal Fillers and Botulinum Toxin Product Offerings
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Introduction and Business Overview
7.6.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hugel Dermal Fillers and Botulinum Toxin Product Offerings
7.6.5 Hugel Recent Development
7.7 Croma-Pharma
7.7.1 Croma-Pharma Company Information
7.7.2 Croma-Pharma Introduction and Business Overview
7.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Croma-Pharma Dermal Fillers and Botulinum Toxin Product Offerings
7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Company Information
7.8.2 Beijing IMEIK Introduction and Business Overview
7.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Beijing IMEIK Dermal Fillers and Botulinum Toxin Product Offerings
7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Information
7.9.2 Bloomage Bio Introduction and Business Overview
7.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bloomage Bio Dermal Fillers and Botulinum Toxin Product Offerings
7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Company Information
7.10.2 Elravie (Humedix) Introduction and Business Overview
7.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product Offerings
7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Company Information
7.11.2 Cleviel (Pharma Research Products) Introduction and Business Overview
7.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product Offerings
7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
7.12.1 Haohai Biological Company Information
7.12.2 Haohai Biological Introduction and Business Overview
7.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Haohai Biological Dermal Fillers and Botulinum Toxin Product Offerings
7.12.5 Haohai Biological Recent Development
7.13 Teoxane
7.13.1 Teoxane Company Information
7.13.2 Teoxane Introduction and Business Overview
7.13.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Teoxane Dermal Fillers and Botulinum Toxin Product Offerings
7.13.5 Teoxane Recent Development
7.14 Sinclair
7.14.1 Sinclair Company Information
7.14.2 Sinclair Introduction and Business Overview
7.14.3 Sinclair Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sinclair Dermal Fillers and Botulinum Toxin Product Offerings
7.14.5 Sinclair Recent Development
7.15 Suneva Medical
7.15.1 Suneva Medical Company Information
7.15.2 Suneva Medical Introduction and Business Overview
7.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Suneva Medical Dermal Fillers and Botulinum Toxin Product Offerings
7.15.5 Suneva Medical Recent Development
7.16 CG Bio
7.16.1 CG Bio Company Information
7.16.2 CG Bio Introduction and Business Overview
7.16.3 CG Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.16.4 CG Bio Dermal Fillers and Botulinum Toxin Product Offerings
7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Information
7.17.2 SciVision Biotech Introduction and Business Overview
7.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.17.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offerings
7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
7.18.1 Prollenium Company Information
7.18.2 Prollenium Introduction and Business Overview
7.18.3 Prollenium Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Prollenium Dermal Fillers and Botulinum Toxin Product Offerings
7.18.5 Prollenium Recent Development
7.19 Bohus BioTech
7.19.1 Bohus BioTech Company Information
7.19.2 Bohus BioTech Introduction and Business Overview
7.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offerings
7.19.5 Bohus BioTech Recent Development
7.20 Caregen
7.20.1 Caregen Company Information
7.20.2 Caregen Introduction and Business Overview
7.20.3 Caregen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Caregen Dermal Fillers and Botulinum Toxin Product Offerings
7.20.5 Caregen Recent Development
7.21 Ipsen
7.21.1 Ipsen Company Information
7.21.2 Ipsen Introduction and Business Overview
7.21.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Ipsen Dermal Fillers and Botulinum Toxin Product Offerings
7.21.5 Ipsen Recent Development
7.22 LIBP
7.22.1 LIBP Company Information
7.22.2 LIBP Introduction and Business Overview
7.22.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.22.4 LIBP Dermal Fillers and Botulinum Toxin Product Offerings
7.22.5 LIBP Recent Development
7.23 US World Meds
7.23.1 US World Meds Company Information
7.23.2 US World Meds Introduction and Business Overview
7.23.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.23.4 US World Meds Dermal Fillers and Botulinum Toxin Product Offerings
7.23.5 US World Meds Recent Development
7.24 Daewoong
7.24.1 Daewoong Company Information
7.24.2 Daewoong Introduction and Business Overview
7.24.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Daewoong Dermal Fillers and Botulinum Toxin Product Offerings
7.24.5 Daewoong Recent Development
7.25 JETEMA
7.25.1 JETEMA Company Information
7.25.2 JETEMA Introduction and Business Overview
7.25.3 JETEMA Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)
7.25.4 JETEMA Dermal Fillers and Botulinum Toxin Product Offerings
7.25.5 JETEMA Recent Development
8 Industry Chain Analysis
8.1 Dermal Fillers and Botulinum Toxin Industrial Chain
8.2 Dermal Fillers and Botulinum Toxin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dermal Fillers and Botulinum Toxin Sales Model
8.5.2 Sales Channel
8.5.3 Dermal Fillers and Botulinum Toxin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Figures, Tables and Charts Available in Dermal Fillers and Botulinum Toxin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
List of TablesTable 1. Dermal Fillers and Botulinum Toxin Market Trends
Table 2. Dermal Fillers and Botulinum Toxin Market Drivers & Opportunity
Table 3. Dermal Fillers and Botulinum Toxin Market Challenges
Table 4. Dermal Fillers and Botulinum Toxin Market Restraints
Table 5. Global Dermal Fillers and Botulinum Toxin Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2019-2024)
Table 7. Global Dermal Fillers and Botulinum Toxin Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Dermal Fillers and Botulinum Toxin Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Dermal Fillers and Botulinum Toxin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Dermal Fillers and Botulinum Toxin
Table 13. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Dermal Fillers and Botulinum Toxin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Dermal Fillers and Botulinum Toxin Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Dermal Fillers and Botulinum Toxin Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Dermal Fillers and Botulinum Toxin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Dermal Fillers and Botulinum Toxin Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Dermal Fillers and Botulinum Toxin Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Dermal Fillers and Botulinum Toxin Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Dermal Fillers and Botulinum Toxin Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Dermal Fillers and Botulinum Toxin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Dermal Fillers and Botulinum Toxin Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Dermal Fillers and Botulinum Toxin Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Dermal Fillers and Botulinum Toxin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Dermal Fillers and Botulinum Toxin Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Dermal Fillers and Botulinum Toxin Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Dermal Fillers and Botulinum Toxin Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Dermal Fillers and Botulinum Toxin Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Dermal Fillers and Botulinum Toxin Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Dermal Fillers and Botulinum Toxin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2019-2024) & (%)
Table 44. Global Dermal Fillers and Botulinum Toxin Sales Value by Region (2025-2030) & (%)
Table 45. Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2019-2024) & (%)
Table 49. Global Dermal Fillers and Botulinum Toxin Sales Volume by Region (2025-2030) & (%)
Table 50. Global Dermal Fillers and Botulinum Toxin Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Dermal Fillers and Botulinum Toxin Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Volume, (2025-2030) & (K Units)
Table 57. AbbVie Company Information
Table 58. AbbVie Introduction and Business Overview
Table 59. AbbVie Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. AbbVie Dermal Fillers and Botulinum Toxin Product Offerings
Table 61. AbbVie Recent Development
Table 62. Galderma Company Information
Table 63. Galderma Introduction and Business Overview
Table 64. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Galderma Dermal Fillers and Botulinum Toxin Product Offerings
Table 66. Galderma Recent Development
Table 67. LG Life Sciences Company Information
Table 68. LG Life Sciences Introduction and Business Overview
Table 69. LG Life Sciences Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. LG Life Sciences Dermal Fillers and Botulinum Toxin Product Offerings
Table 71. LG Life Sciences Recent Development
Table 72. Merz Company Information
Table 73. Merz Introduction and Business Overview
Table 74. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Merz Dermal Fillers and Botulinum Toxin Product Offerings
Table 76. Merz Recent Development
Table 77. Medytox Company Information
Table 78. Medytox Introduction and Business Overview
Table 79. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Medytox Dermal Fillers and Botulinum Toxin Product Offerings
Table 81. Medytox Recent Development
Table 82. Hugel Company Information
Table 83. Hugel Introduction and Business Overview
Table 84. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Hugel Dermal Fillers and Botulinum Toxin Product Offerings
Table 86. Hugel Recent Development
Table 87. Croma-Pharma Company Information
Table 88. Croma-Pharma Introduction and Business Overview
Table 89. Croma-Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Croma-Pharma Dermal Fillers and Botulinum Toxin Product Offerings
Table 91. Croma-Pharma Recent Development
Table 92. Beijing IMEIK Company Information
Table 93. Beijing IMEIK Introduction and Business Overview
Table 94. Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Beijing IMEIK Dermal Fillers and Botulinum Toxin Product Offerings
Table 96. Beijing IMEIK Recent Development
Table 97. Bloomage Bio Company Information
Table 98. Bloomage Bio Introduction and Business Overview
Table 99. Bloomage Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Bloomage Bio Dermal Fillers and Botulinum Toxin Product Offerings
Table 101. Bloomage Bio Recent Development
Table 102. Elravie (Humedix) Company Information
Table 103. Elravie (Humedix) Introduction and Business Overview
Table 104. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product Offerings
Table 106. Elravie (Humedix) Recent Development
Table 107. Cleviel (Pharma Research Products) Company Information
Table 108. Cleviel (Pharma Research Products) Introduction and Business Overview
Table 109. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product Offerings
Table 111. Cleviel (Pharma Research Products) Recent Development
Table 112. Haohai Biological Company Information
Table 113. Haohai Biological Introduction and Business Overview
Table 114. Haohai Biological Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Haohai Biological Dermal Fillers and Botulinum Toxin Product Offerings
Table 116. Haohai Biological Recent Development
Table 117. Teoxane Company Information
Table 118. Teoxane Introduction and Business Overview
Table 119. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Teoxane Dermal Fillers and Botulinum Toxin Product Offerings
Table 121. Teoxane Recent Development
Table 122. Sinclair Company Information
Table 123. Sinclair Introduction and Business Overview
Table 124. Sinclair Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Sinclair Dermal Fillers and Botulinum Toxin Product Offerings
Table 126. Sinclair Recent Development
Table 127. Suneva Medical Company Information
Table 128. Suneva Medical Introduction and Business Overview
Table 129. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Suneva Medical Dermal Fillers and Botulinum Toxin Product Offerings
Table 131. Suneva Medical Recent Development
Table 132. CG Bio Company Information
Table 133. CG Bio Introduction and Business Overview
Table 134. CG Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. CG Bio Dermal Fillers and Botulinum Toxin Product Offerings
Table 136. CG Bio Recent Development
Table 137. SciVision Biotech Company Information
Table 138. SciVision Biotech Introduction and Business Overview
Table 139. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offerings
Table 141. SciVision Biotech Recent Development
Table 142. Prollenium Company Information
Table 143. Prollenium Introduction and Business Overview
Table 144. Prollenium Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Prollenium Dermal Fillers and Botulinum Toxin Product Offerings
Table 146. Prollenium Recent Development
Table 147. Bohus BioTech Company Information
Table 148. Bohus BioTech Introduction and Business Overview
Table 149. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offerings
Table 151. Bohus BioTech Recent Development
Table 152. Caregen Company Information
Table 153. Caregen Introduction and Business Overview
Table 154. Caregen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Caregen Dermal Fillers and Botulinum Toxin Product Offerings
Table 156. Caregen Recent Development
Table 157. Ipsen Company Information
Table 158. Ipsen Introduction and Business Overview
Table 159. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. Ipsen Dermal Fillers and Botulinum Toxin Product Offerings
Table 161. Ipsen Recent Development
Table 162. LIBP Company Information
Table 163. LIBP Introduction and Business Overview
Table 164. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 165. LIBP Dermal Fillers and Botulinum Toxin Product Offerings
Table 166. LIBP Recent Development
Table 167. US World Meds Company Information
Table 168. US World Meds Introduction and Business Overview
Table 169. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 170. US World Meds Dermal Fillers and Botulinum Toxin Product Offerings
Table 171. US World Meds Recent Development
Table 172. Daewoong Company Information
Table 173. Daewoong Introduction and Business Overview
Table 174. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 175. Daewoong Dermal Fillers and Botulinum Toxin Product Offerings
Table 176. Daewoong Recent Development
Table 177. JETEMA Introduction and Business Overview
Table 178. JETEMA Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. JETEMA Dermal Fillers and Botulinum Toxin Product Offerings
Table 180. JETEMA Recent Development
Table 181. JETEMA Company Information
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Dermal Fillers and Botulinum Toxin Downstream Customers
Table 185. Dermal Fillers and Botulinum Toxin Distributors List
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Fillers and Botulinum Toxin Product Picture
Figure 2. Global Dermal Fillers and Botulinum Toxin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Dermal Fillers and Botulinum Toxin Sales Volume (2019-2030) & (K Units)
Figure 5. Global Dermal Fillers and Botulinum Toxin Sales Price (2019-2030) & (USD/Unit)
Figure 6. Dermal Fillers and Botulinum Toxin Report Years Considered
Figure 7. Global Dermal Fillers and Botulinum Toxin Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Dermal Fillers and Botulinum Toxin Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermal Fillers and Botulinum Toxin Revenue in 2023
Figure 10. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Dermal Fillers Picture
Figure 12. Botulinum Toxin Picture
Figure 13. Global Dermal Fillers and Botulinum Toxin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Dermal Fillers and Botulinum Toxin Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Dermal Fillers and Botulinum Toxin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Dermal Fillers and Botulinum Toxin Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Cosmetic
Figure 19. Product Picture of Medical
Figure 20. Global Dermal Fillers and Botulinum Toxin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Dermal Fillers and Botulinum Toxin Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Dermal Fillers and Botulinum Toxin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Dermal Fillers and Botulinum Toxin Price by Application (2019-2030) & (USD/Unit)
Figure 25. North America Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Dermal Fillers and Botulinum Toxin Sales Volume (%), (2019-2030)
Figure 37. United States Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 43. China Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 45. China Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 55. India Dermal Fillers and Botulinum Toxin Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Dermal Fillers and Botulinum Toxin Sales Value by Type (%), 2023 VS 2030
Figure 57. India Dermal Fillers and Botulinum Toxin Sales Value by Application (%), 2023 VS 2030
Figure 58. Dermal Fillers and Botulinum Toxin Industrial Chain
Figure 59. Dermal Fillers and Botulinum Toxin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed